Pfizer's Strong Late-Stage Pipeline Can Drive Long-Term Growth

• click to rate

  Posted by Two Blokes Jul 1 - Filed in Stock - 2 views
  
  PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.